Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PRDM16 suppresses HIF-targeted gene expression in kidney cancer

The Journal of Experimental Medicine(2020)10.1084/jem.20191005Source: DataRank Database

PRDM16 suppresses HIF-targeted gene expression in kidney cancer is a research paper published in The Journal of Experimental Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 47 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access47 citations

Download PDF

Cite:

Linked data & code

geo ensembl hpa

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: greenTopics (50)IDs (PubMed, PMC)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Hyeyoung Nam ORCID,Sandeep B. Shelar ORCID,Darshan S. Chandrashekar ORCID,Garrett J. Brinkley ORCID,Suman Karki ORCID

Live enrichment

PubMed:32251515 PMC:PMC7971134

O’Neal Comprehensive Cancer Center

Grant: P30CA013148

National Cancer Institute

Grant: R01CA200653

Department of Veterans Affairs

Grant: I01BX002930

National Institutes of Health

Grant: 2I01BX002930-09

HDAC7-driven metabolic remodeling in renal tumor progression

National Institutes of Health

Grant: 2R01CA200653-06A1

Interaction between the Epitranscriptome and Metabolism in L-2HG Driven Kidney Cancer

National Institutes of Health

Grant: 2P30CA013148-34

TISSUE PROCUREMENT

National Institutes of Health

greenLicense: CC BY NC SA

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7971134

publisherhttps://rupress.org/jem/article-pdf/doi/10.1084/jem.20191005/1823646/jem_20191005.pdf

Europe_PMChttps://europepmc.org/articles/PMC7971134

Europe_PMChttps://europepmc.org/articles/PMC7971134?pdf=render

https://doi.org/10.1084/jem.20191005

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

MitochondriaAnimalsHumansMiceCarcinoma, Renal CellKidney NeoplasmsAlcohol OxidoreductasesDNA-Binding ProteinsMembrane GlycoproteinsSemaphorinsTranscription FactorsXenograft Model Antitumor AssaysWound HealingCell ProliferationCell MovementDNA MethylationTranscription, GeneticEpigenesis, GeneticGene Expression Regulation, NeoplasticGene SilencingPhenotypeModels, BiologicalHypoxia-Inducible Factor 1, alpha SubunitPromoter Regions, GeneticColforsinRosiglitazone

Keywords

Membrane GlycoproteinsColforsinDNA MethylationHypoxia-Inducible Factor 1, alpha SubunitModels, BiologicalArticleKidney NeoplasmsEpigenesis, GeneticMitochondriaDNA-Binding ProteinsGene Expression Regulation, NeoplasticAlcohol OxidoreductasesMicePhenotypeCell MovementAnimalsHumansGene SilencingPromoter Regions, GeneticCarcinoma, Renal CellCell Proliferation

Sustainable Development Goals

SDG 3: 3. Good health

PRDM16 suppresses HIF-targeted gene expression in kidney cancer

FAIR Checklist

Authors (15)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)